Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Gabapentin From Nerpentin 600 mg (Test ) F.C.T (Aman Pharma ,Egypt.) and Gabapentin From Neurontin 300 mg (Referance ) H.G.C. ( Pfizer Egypt)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

March 7, 2021

Study Completion Date

March 7, 2021

Conditions

Healthy

Interventions

DRUG

Gabapentin

1 tablet contains 600 mg Gabapentin

DRUG

Neurontin

2 capsule contains 2\*300 = 600 mg Gabapentin

Trial Locations (1)

Pharma Guide, Cairo